Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Iomeprol 300 and Iomeprol 400 for auto-segmentation efficiency in coronary MD-CTA
2005-006052-37Phase 4Completed
- Sponsor
- Bracco Group
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of iomeprol in coronary arteriosclerosis (2 arms), sponsored by Bracco Group. Primary endpoint: Percentage of automated coronary segmentation length vs manual segment length. Started Mar 2006; status: completed.
02
Drugs
iomeprol
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2005-006052-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006052-37.